VOL. XCIV, NO. 247
WIDE MOAT STOCKS COMPARISON
Stock Comparison
GSK plc vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
GSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Pfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Pfizer Inc. leads (58 / 100 vs 57 / 100 for GSK plc).
- Segment focus: GSK plc has 3 segments (43.7% in Specialty Medicines); Pfizer Inc. has 5 segments (37.5% in Primary Care).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: GSK plc has 1 moat types across 1 domains; Pfizer Inc. has 1 across 1.
Primary market context
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
43.7%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
37.5%
Side-by-side metrics
Moat coverage
Shared moat types
GSK plc strengths
No unique moat types yet.
Pfizer Inc. strengths
No unique moat types yet.
Segment mix
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Competitive
General Medicines
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Hospital and Biosimilars
Competitive
Pfizer CentreOne
Competitive
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.